综合
科技
娱乐
社区
购物
财经
开发
校务
政务
专栏
报刊
设计
The Lancet Microbe
1
[Review] MERS-CoV in Africa: a One Health review of the silent reservoir
2
[Articles] A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials
3
[Personal View] Importance of faecal sample collection in prospective cohort studies to evaluate the effect of the gut microbiome on cancer development
4
[Articles] Host and environmental factors associated with upper respiratory tract mycobiota in healthy individuals: a cross-sectional observational study
5
[Articles] Epidemiology and phylogenomic characterisation of the 2025 Ebola virus disease outbreak in Bulape, Kasaï province, Democratic Republic of the Congo: a retrospective observational study
6
[Articles] Evaluation of the laboratory assessment process for A Clinically Oriented Antimicrobial Resistance Surveillance Network (ACORN-LAP) in low-income and middle-income countries: a multicountry, cross-sectional analysis with longitudinal quality mo
7
[Articles] Data-driven diagnostic reform in Ethiopia's transition to pLDH-based malaria rapid diagnostic tests amid rising pfhrp2/3 deletions: a multisite, facility-based, cross-sectional study
8
[Editorial] AMR stewardship needs microbiology
9
[News] Highlights of ICOPA 2026
10
[Personal View] Antimicrobial resistance surveillance: a crucial pillar for sustainable leprosy control and chemoprophylaxis
The Lancet Neurology
1
[Review] The role of lifestyle interventions in symptom management and disease modification in Parkinson's disease
2
[Comment] Advances in understanding sudden unexpected death in people with drug-resistant epilepsy
3
[Articles] Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study
The Lancet Infectious Diseases
1
[Comment] Pertussis: taking aim at the nose in schoolchildren
2
[Articles] Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6–17 years: a randomised, active-controlled and plac
3
[Review] Methodological quality and risk of bias in non-randomised comparative effectiveness studies of invasive mould infections: a systematic review
4
[Corrections] Correction to Lancet Infectious Dis; published online Aug 25 https://doi.org/10.1016/S1473-3099(26)00318-X
5
[Articles] Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial
6
[Correspondence] Pragmatic tuberculosis trials must measure what determines implementation
7
[Comment] South Sudan's first 100 days of Bundibugyo Ebola readiness
8
[Personal View] Is a tiered classification framework needed for sexually transmitted infections?
9
[Articles] Immunogenicity and safety of an MF59-adjuvanted cell-derived higher-dose quadrivalent influenza vaccine (aQIVc) in adults aged 50 years or older: a phase 3 randomised controlled trial
10
[Comment] Developing a better flu vaccine
The Lancet HIV
1
[Feature] Early lessons from lenacapavir PrEP roll-out in Zimbabwe
2
[Articles] Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study
3
[Articles] Trends in HIV-1 transmission in Switzerland: a retrospective molecular epidemiology study
4
[Comment] Psychedelic-assisted therapy research for people with HIV
5
[Editorial] Turkish Government crackdown on HIV and LGBTQ+ groups
6
[Review] Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care
7
[Comment] Advancing a fixed-dose combination for children with HIV
8
[Articles] Expediting a UNIVERSAL first-line regimen of a dolutegravir–emtricitabine–tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1–2, pharmacokinetic, safety, and antivir
9
[Articles] Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa
10
[Comment] Low-level viraemia in children living with HIV
The Lancet Healthy Longevity
1
[Articles] Effect of pre-existing dementia on cancer-specific and all-cause mortality in patients with cancer in Denmark: a population-based cohort study
2
[Personal View] Sarcopenia as a manifestation of systemic energetic failure with ageing
3
[Feature] Highlights of AAIC 2026
4
[Comment] The frailty–influenza paradox: enhanced risk of severe infection, yet greater high-dose vaccine effectiveness
5
[Articles] Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2
6
[Comment] Climate change and medication safety in older adults: an overlooked priority for healthy ageing
7
[Comment] Addressing the needs of older people in Venezuela: beyond the earthquakes and humanitarian health crisis
8
[Articles] Supervised multimodal prehabilitation of older patients with frailty or prefrailty before elective surgery: a multicentre randomised controlled outcome assessor-blinded trial
9
[Editorial] Ageing Well for Indigenous Peoples: Closing the Health Equity Gap
10
[Review] Effectiveness of digital health technologies for post-discharge follow-up and management in older adults: a systematic review
The Lancet Global Health
1
[Articles] The burden and long-term outcomes of diagnosed and underdiagnosed COPD across diverse communities from high-income, middle-income, and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study
2
[Comment] Chewing tobacco: the neglected component of the tobacco epidemic
3
[Articles] Global, regional, and national burden of exposure to chewing tobacco, 1990–2023: a systematic analysis of the Global Burden of Disease Study 2023
4
[Health Policy] Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials
5
[Articles] Hookworm and Strongyloides stercoralis infections in school-age children and cohabiting dogs in Cambodia following 5 years of bi-annual mass drug administration: a cross-sectional observational study
6
[Articles] Mid-upper arm circumference of preschool-aged children during conflict transition in the Gaza Strip: a cross-sectional nutritional surveillance study
7
[Comment] When time is not the same: pre-hospital delay and perforation in global appendicitis care
8
[Articles] Pre-hospital time and risk of perforation in patients with acute appendicitis in 112 countries (AlliGatOr): an international, prospective, observational cohort study
9
[Articles] Diagnostic performance and testing costs of pooled testing for molecular detection of tuberculosis in seven countries: a prospective, observational, diagnostic accuracy study
10
[Articles] Burden of schistosomiasis in Ethiopia following 10 years of preventive chemotherapy: a national cross-sectional geostatistical survey
The Lancet Gastroenterology & Hepatology
1
[Articles] Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study
2
[Review] Pain management in chronic pancreatitis: beyond opioids
3
[Articles] Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
4
[Comment] Lessons from the European LiverScreen and Chinese LiverHealth projects
5
[Articles] Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study
6
[Comment] Decompensation unmasks renal susceptibility in cirrhosis
7
[Articles] Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study
8
[Articles] Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
9
[Correspondence] Incidence of inflammatory bowel disease in Jakarta, Indonesia, 2021–24
10
[Articles] Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis
The Lancet Diabetes & Endocrinology
1
[Articles] Efficacy and safety of low-dose IL-2 in people with newly diagnosed type 1 diabetes (DIABIL-2): a double-blind, multicentre, randomised, placebo-controlled, phase 2b trial
2
[Comment] IL-2 and immunoregulatory therapies in newly diagnosed type 1 diabetes
3
[Comment] What Mauritius teaches us about diabetes surveillance
4
[Articles] Trends in prevalence of type 2 diabetes and intermediate hyperglycaemia in Mauritius from 1987 to 2021 based on results from the oral glucose tolerance test: a repeated cross-sectional study
5
[Editorial] Safeguarding paediatric metabolic health
6
[Review] Diabetes and the role of primary care: a global perspective
7
[Personal View] Disease modification outcomes in type 2 diabetes: a modified Delphi
8
[Comment] Petrelintide and the evolving role of amylin agonism in obesity
9
[Articles] Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial
10
[Review] New genomic understanding and challenges in clinical care of Turner syndrome
The Lancet Child & Adolescent Health
1
[Articles] Global reference values for daily steps in preschool children (SUNRISE): a cross-sectional analysis from 44 countries
2
[Articles] Health service use of young people after mental health admission far from home: a retrospective cohort study in England
3
[Articles] Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-lab
4
[Health Policy] Opportunities for advancing paediatric medical device access: regulatory frameworks in the EU and USA
5
[Articles] Injury burden among adolescents and young adults aged 10–24 years in the Arab region, 1990–2023: a systematic analysis of the Global Burden of Disease Study 2023
6
[Comment] An injury burden crisis among young people in the Arab region
7
[Comment] The pathogenic illusion of youth incarceration: a call for abolition medicine in Europe
8
[Comment] An urgent opportunity to ensure children's access to oral post-exposure prophylaxis trials for Bundibugyo virus disease
9
[Articles] Comparative effectiveness of clarithromycin and azithromycin for pertussis in hospitalised infants in Italy: a multicentre target trial emulation study
10
[Review] Methylation profile scores in child and adolescent health: a practical guide
« 上一页
1
…
17
18
19
20
21
…
886
下一页 »